SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-05-008614
Filing Date
2005-02-28
Accepted
2005-02-28 16:41:49
Documents
3
Period of Report
2005-02-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a05-4247_18k.htm 8-K 91881
2 EX-99.1 a05-4247_1ex99d1.htm EX-99.1 18083
3 EX-99.2 a05-4247_1ex99d2.htm EX-99.2 19594
  Complete submission text file 0001104659-05-008614.txt   131588
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 05646154
SIC: 2834 Pharmaceutical Preparations